FFRCT RIPCORD Study: Availability of HeartFlow FFRCT Analysis Changes the Management of Patients with Coronary Artery Disease
PARIS — May 19, 2015 — Adding the HeartFlow® FFRCT Analysis to a standard coronary CT angiogram (cCTA) may change the course of treatment in more than one third of patients with coronary artery disease, according to a study presented today at the EuroPCR 2015 conference. Results of the FFRCT RIPCORD study, presented by Prof. Nick Curzen of […]
Late-Breaking Data Reinforces How the HeartFlow Analysis Can Help Physicians Precisely Stratify Heart Disease Patients and Deliver More Personalized Care
Late-Breaking Data Reinforces How the HeartFlow Analysis Can Help Physicians Precisely Stratify Heart Disease Patients and Deliver More Personalized Care
Fast Company Names HeartFlow One of the World’s Most Innovative Companies
Fast Company Names HeartFlow One of the World’s Most Innovative Companies
HeartFlow Survey: Fewer than 1/3 of Americans Know Biggest Health Threat
New Consumer Survey Data Reveals Striking Misconceptions around Heart Health, Medical Anxieties and More REDWOOD CITY, Calif. – February 7, 2019 – HeartFlow, Inc. today announced the findings of a new consumer survey of more than 1,500 adults across the United States that sheds light on dangerous misconceptions and lack of awareness around heart disease, the leading killer […]
New JACC Publication Reinforces Value of a Coronary CTA + HeartFlow Analysis- Guided Pathway for Diagnosing Heart Disease
REDWOOD CITY, Calif. – January 15, 2019 – HeartFlow, Inc. today announced the publication of the PACIFIC substudy showing that the HeartFlow FFRCT Analysis demonstrates the highest diagnostic performance for detecting coronary artery disease (CAD) compared to other non-invasive tests. The HeartFlow Analysis is a non-invasive, personalized cardiac test that starts with a standard coronary computed tomography angiogram (CTA). […]
HeartFlow Initiates PRECISE Randomized Clinical Trial
New trial of more than 2,000 patients will evaluate a precision-testing pathway for coronary artery disease including non-invasive coronary CTA + the HeartFlow Analysis as compared to the conventional pathway for diagnosis REDWOOD CITY, Calif. – December 6, 2018 – HeartFlow, Inc. today announced the start of the Prospective Randomized Trial of the Optimal Evaluation of Cardiac Symptoms […]
HeartFlow Receives National Reimbursement Approval in Japan
HeartFlow Analysis to be covered by Japan’s health insurance system, making it more broadly available to patients with suspected coronary artery disease REDWOOD CITY, Calif. – November 14, 2018 – HeartFlow, Inc. today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommendation by the Central Social Insurance Medical Council (Chuikyo) to provide […]
HeartFlow Analysis Enables Physicians to Confidently and Safely Differentiate Patients in Need of Invasive Treatment and Patients Who Can be Managed Medically for Coronary Artery Disease
Global Studies of Over 8,500 Patients Demonstrate Marked Improvement in Outcomes When Physicians Utilize the HeartFlow Analysis in Diagnosis and Treatment MUNICH, GERMANY, August 25, 2018 – Late-breaking data published and presented today confirm that the non-invasive HeartFlow® FFRCT Analysis enables physicians to effectively differentiate patients in need of coronary stenting or bypass surgery from those who […]
NHS Hospitals Turn to Deep Learning and Advanced Algorithms to Fight Heart Disease
NHS Hospitals Turn to Deep Learning and Advanced Algorithms to Fight Heart Disease
HeartFlow Announces New Commercial Coverage with UnitedHealthcare, Largest Health Insurer in U.S.
HeartFlow Analysis Now Covered for more than 75% of Americans. REDWOOD CITY, Calif. – June 27, 2018 – HeartFlow, Inc. today announced that UnitedHealthcare now covers the HeartFlow FFRCT Analysis, extending access to their 45 million beneficiaries. With this new coverage, more than 235 million people in the United States now have access to the HeartFlow Analysis—significantly advancing HeartFlow’s […]